Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K on December 11, 2005, reporting changes to its non-employee Director compensation structure, effective January 1, 2006. The primary purpose of these adjustments, approved by the Board of Directors following a consultant's review, is to enhance director recruitment and retention while better aligning director interests with those of long-term shareholders. The key changes include an increase in cash retainers and annual fees for committee chairs and certain other roles, the elimination of meeting attendance fees, and a shift in equity compensation. Instead of stock options with a one-year vesting period, directors will now receive deferred stock awards that vest at grant but are distributed one year after their board service terminates. Additionally, the company significantly raised its director share ownership guideline from $90,000 to $500,000.
Key Highlights
- 1Changes to non-employee Director compensation effective January 1, 2006.
- 2Increase in cash retainers and annual fees for committee chairmen, Audit Committee members, and the Lead Director.
- 3Elimination of fees for individual meeting attendance.
- 4Shift in equity compensation from stock options to deferred stock awards with delayed distribution.
- 5Significant increase in director share ownership guideline from $90,000 to $500,000.
- 6Changes aim to attract/retain qualified directors and align interests with long-term shareholders.
- 7Compensation adjustments were based on recommendations from an external compensation consultant.